Vertical: HealthcareBase Year: 202416 Sections
Market Size (2024)
$3.29B
Projected (2035)
$6.38B
CAGR (2019–2035)
7.4%
Key Players
10+
This report covers Implantable Port Market with forecasts from 2019 to 2035. 10 key companies are profiled.
The Implantable Port Market market is projected to grow at a CAGR of 7.4% from 2019 to 2035.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansINTRODUCTION
Increasing incidences of chronic diseases across the globe, technological advancements, and better healthcare access are the major factors driving the growth of the global implantable port market. However, the high cost of implantation and surgical risks are expected to hinder market growth. Nevertheless, the expansion in emerging markets and the growing aging population are anticipated to create lucrative opportunities for the market.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2024
Historical Period
2019 – 2023
Forecast Period
2025 – 2035
Primary Interviews
150+
Historical data (2019–2024) and forecast period (2024–2035)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter's Five Forces model is a framework to study the global implantable port market. Strategic business managers trying to gain an edge over competing firms in the global implantable port market can utilize this model to better comprehend the industry in which the firm operates. The components of each of the forces and the degree of impact of each component in the context of the global implantable port market have been broken down and analyzed.
PORTER'S FIVE FORCES Analysis: Global Implantable Port Market
Threat of New Entrants
The threat of new entrants in the global implantable port market is moderate. While the market offers lucrative opportunities, particularly due to the increasing demand for long-term medical treatments, new entrants face significant barriers to entry. These include the high initial investment required for research and development, regulatory approval processes, and the need for skilled personnel to perform complex surgeries. Additionally, established players benefit from strong brand recognition and relationships with hospitals and healthcare providers. Despite these barriers, the market is fragmented, allowing room for new companies to enter by offering innovative solutions, potentially targeting underserved niches or regions. However, the high cost of implantation and the need for specialized knowledge still present substantial challenges for new market players.
Bargaining Power of Suppliers
The bargaining power of suppliers in the implantable port market is relatively low to moderate. While there are a number of suppliers of raw materials such as medical-grade plastics, silicone, and metals, most of these components are standardized and readily available from multiple suppliers. The fragmented nature of the market also means that implantable port manufacturers have access to a wide range of suppliers, limiting any single supplier’s power. However, suppliers of highly specialized components, such as advanced materials used in port construction or specialized manufacturing technologies, may wield more power in setting prices and terms, especially as the demand for higher-quality, durable products increases. Nonetheless, overall, the bargaining power of suppliers remains manageable for most companies in the market.
Threat of Substitutes
The threat of substitutes in the global implantable port market is moderate. While alternative treatment methods exist, such as external catheters, traditional intravenous (IV) lines, and peripherally inserted central catheters (PICC), implantable ports provide advantages in terms of convenience, long-term access, and lower infection rates. Substitutes like external catheters and PICCs are often less comfortable, have a higher risk of infection, and may require more frequent replacements. However, for some patient groups, especially those who need short-term or less intensive therapy, substitutes may be a viable option, reducing the demand for implantable ports. As such, the market will continue to be impacted by these alternatives, but the demand for implantable ports, particularly for long-term treatments, is expected to remain strong.
Bargaining Power of Buyers
The bargaining power of buyers in the implantable port market is moderate. Healthcare providers, especially large hospitals, clinics, and cancer treatment centers, typically purchase implantable ports in bulk, which can give them some negotiating leverage over prices and terms. However, given the highly specialized and medical nature of implantable ports, buyers may be less price-sensitive than in other sectors. Additionally, the fragmented market allows for competition among manufacturers, giving buyers a range of options in terms of product features, pricing, and quality. Despite this, the importance of ensuring patient safety and minimizing complications means that buyers are often more focused on quality and reliability, which can reduce the influence of price negotiations. However, in price-sensitive markets or public healthcare systems, buyers may still exert pressure on suppliers to reduce costs.
Intensity of Rivalry
The intensity of rivalry in the global implantable port market is high, particularly given its fragmented nature. There are a number of established players in the market, as well as several smaller companies offering innovative solutions. The competition among these firms is driven by factors such as product quality, technological advancements, pricing, and customer service. As implantable ports are used for critical and long-term treatments, there is a strong focus on product reliability, safety, and ease of use, which creates an intense competitive environment. In addition, companies are investing in research and development to improve port designs, materials, and features to differentiate themselves in the market. The growing demand for implantable ports, coupled with the presence of several players, contributes to high competitive pressure and frequent innovation in the sector, making rivalry a significant factor in shaping market dynamics.
Impact of covid-19 on the Global Implantable Port Market
The impact of COVID-19 on the global implantable port market was profound, with both short-term disruptions and long-term implications for industry. In the early stages of the pandemic, the healthcare sector experienced significant strain, with hospitals and medical facilities focusing their resources on managing COVID-19 cases. As a result, many non-urgent medical procedures, including elective surgeries and routine treatments, were postponed or canceled. This led to a temporary reduction in the number of implantable port implantations, as healthcare providers prioritized critical care over elective or long-term treatments for conditions like cancer or cardiovascular diseases. The delay in treatment resulted in a slowdown in the demand for implantable ports during the initial phases of the pandemic.
In addition to disruptions in medical procedures, the global supply chain for medical devices, including implantable ports, was also significantly impacted by COVID-19. Lockdowns, travel restrictions, and factory closures in key manufacturing regions caused delays in production and distribution. This disruption led to shortages in critical medical supplies, including implantable ports, particularly in regions heavily impacted by the pandemic. Healthcare systems in both developed and developing countries faced challenges in securing a consistent supply of devices due to these logistical issues. Moreover, some manufacturers struggled with a reduced workforce, making it difficult to meet the demand for implantable ports during the height of the pandemic.
Despite these setbacks, the pandemic also highlighted the importance of long-term care solutions, which contributed to a recovery in demand for implantable ports. With the rise in chronic disease management and the shift towards providing care for non-COVID conditions remotely or in outpatient settings, healthcare providers began to recognize the role of implantable ports in facilitating long-term treatments. The pandemic underscored the necessity of minimizing patient visits to healthcare facilities to reduce the risk of exposure to the virus, leading to increased interest in devices that could support prolonged intravenous therapy outside hospital settings. This trend was particularly evident in cancer care, where patients undergoing chemotherapy or immunosuppressive therapy require frequent treatments, making implantable ports a safer, more convenient alternative to frequent venipuncture.
In the long term, the pandemic accelerated the digital transformation of the healthcare industry, leading to greater adoption of telemedicine and home healthcare services. This shift created new opportunities for implantable port usage, especially in outpatient and homecare settings.
Market estimates by geography (2035)
InsightNorth America leads with $2.42B by 2035, while Asia-Pacific is projected to grow fastest at a 9.7% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2024 | 2035 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $894.21M | $1.61B | $2.42B | 6.4% | 38% |
| Europe | $596.34M | $1.17B | $1.93B | 7.6% | 30% |
| Asia-Pacific | $366.52M | $848.62M | $1.61B | 9.7% | 25% |
| South America | $102.48M | $170.75M | $233.05M | 5.3% | 4% |
| Middle East and Africa | $77.83M | $141.57M | $201.76M | 6.1% | 3% |
| Total | $2.04B | $3.94B | $6.38B | 7.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$6.38B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Titanium | $4.20B | 8.1% | 66% |
| Silicone | $1.28B | 6.0% | 20% |
| Polyurethane | $910.08M | 6.5% | 14% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Implantable Port Market covering market dynamics, competitive landscape, and strategic outlook.
The Implantable Port Market market is projected to reach $6.38B by 2035, growing at 7.4% CAGR. The Titanium segment holds the largest share.
INTRODUCTION
Increasing incidences of chronic diseases across the globe, technological advancements, and better healthcare access are the major factors driving the growth of the global implantable port market. However, the high cost of implantation and surgical risks are expected to hinder market growth. Nevertheless, the expansion in emerging markets and the growing aging population are anticipated to create lucrative opportunities for the market.
Increasing Incidences of Chronic Diseases across the globe
The global implantable port market is experiencing significant growth, driven by the increasing need for reliable and effective long-term access to the vascular system for patients with chronic conditions. Implantable ports, which are small medical devices implanted under the skin, allow healthcare providers to administer medications, fluids, and nutrients directly into the bloodstream, providing a crucial solution for patients requiring prolonged treatments such as chemotherapy, dialysis, and intravenous nutrition.
The rising prevalence of chronic diseases, including cancer, cardiovascular disorders, and autoimmune conditions, has played a pivotal role in boosting the demand for implantable ports. As patients with cancer, for example, often require frequent chemotherapy sessions, the convenience and reduced discomfort provided by implantable ports are significant factors driving their adoption. With cancer being one of the leading causes of death globally, healthcare systems are increasingly relying on implantable ports to manage long-term treatments and improve patient quality of life. Furthermore, the increase in the incidences of various types of cancer across the world is the major factor anticipating the growth of the market. Cancer is one of the leading causes of death globally, and the incidence of cancer is expected to continue rising in the coming years. This rise can be attributed to several factors such as an aging population, unhealthy lifestyle choices, environmental factors, and genetic predisposition. For instance, as per the World Health Organization, it was estimated that about 20 million new cancer cases were diagnosed in 2022.
Furthermore, according to the Global Cancer Observatory, it was estimated that about 49.2% of cancer cases were diagnosed in Asia, 22.4% in Europe, 13.4% in Latin America. 7.8% in Caribbean and others (7.2%) in 2022. In addition to cancer, other chronic conditions such as renal failure, which require regular dialysis, and neurological disorders, often demanding long-term drug infusions, are also contributing to the growing need for implantable ports. These devices offer a safer and more efficient alternative to frequent venipunctures, minimizing the risk of infection, thrombosis, and other complications associated with repeated needle insertions.
Further, neurological diseases like epilepsy, multiple sclerosis (MS), and Parkinson's disease sometimes require intravenous (IV) medications for symptom management or disease-modifying treatments. Implantable ports provide a more convenient and reliable access point for administering these medications over time, especially when the patient requires regular IV therapy. For instance, in February 2024, the World Health Organization reported that around 50 million people worldwide were suffering from epilepsy, and nearly 80% of people with epilepsy live in low- and middle-income countries. Also, in 2022, a Parkinson’s Foundation-backed study revealed that virtually 90,000 people are diagnosed with Parkinson’s disease each year in the US. Similarly, the Alzheimer’s Disease Foundation reported that in 2020 there were around 50 million people living with dementia around the world.
Additionally, the increasing incidence of cardiovascular conditions worldwide is burgeoning the growth of the generic drugs market. As per the American Heart Association, there were nearly 244.1 million people living with ischemic heart disease (IHD) in 2020. Also, in May 2023, the Centers for Disease Control and Prevention reported that 805,000 people in the US have heart attacks every year. Furthermore, implantable ports are particularly beneficial for patients with rheumatoid arthritis (RA) and inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis, as these conditions often require long-term or frequent intravenous treatments. For instance, as per the World Health Organization, 18 million people were suffering from rheumatoid arthritis in 2019, of which 70% were women and 55% were older than 55 years. Moreover, Crohn’s & Colitis UK suggested that one in every 123 people in the UK will have had either Crohn’s disease or ulcerative colitis in 2022.
Consequently, the global implantable port market is growing rapidly due to the increasing demand for long-term vascular access in patients with chronic conditions like cancer, cardiovascular diseases, neurological disorders, and autoimmune diseases. These devices provide a safer, more efficient method for administering medications, fluids, and nutrients, reducing complications associated with repeated venipunctures. As the prevalence of chronic diseases rises worldwide, implantable ports are becoming an essential solution for managing prolonged treatments, improving patient quality of life, and optimizing healthcare delivery.
Technological Advancements
Technological advancements are significantly boosting the growth of the global implantable port market by enhancing the functionality, safety, and efficiency of these devices. Innovations in materials science have led to the development of more durable and biocompatible ports, reducing the risk of infections and improving patient outcomes. For instance, in July 2023, AngioDynamics received FDA 510(k) clearance and CE Mark approval for its SmartPort+ implantable port product, which is designed for patients requiring long-term access to the central venous system for blood specimen withdrawal and administration of fluids. The SmartPort+ device incorporates advanced vortex technology with a round chamber and tangential outlet, which hyper-cleanses the entire chamber, along with a BioFlo catheter utilizing Endexo polymer technology. This technology is blended into the polyurethane from which the catheter is made, enhancing performance and minimizing the risk of clot formation. Additionally, advancements in medical imaging and minimally invasive surgical techniques have made the implantation process more precise and less invasive, minimizing recovery time and complications. The integration of smart technologies, such as wireless monitoring and remote access for healthcare providers, has further elevated the capabilities of implantable ports, allowing for better management of chronic conditions. As a result, these technological improvements are driving demand for implantable ports across various medical fields, including oncology, hematology, and long-term care, thereby fueling market growth.
Better Healthcare Access
As healthcare infrastructure continues to improve, especially in developing regions, more patients are gaining access to advanced medical treatments that were once out of reach due to limited resources and technological availability. Healthcare systems in these regions are increasingly integrating innovative medical technologies to address the growing burden of chronic conditions such as cancer, cardiovascular diseases, and autoimmune disorders. Implantable ports, which provide long-term, reliable access to the vascular system for intravenous treatments, have become a key component of this healthcare evolution. These devices offer significant advantages, such as reducing the need for repeated venipuncture, minimizing the risk of complications like infections or thrombosis, and enhancing patient comfort, particularly for those undergoing frequent treatments like chemotherapy or dialysis. The adoption of implantable ports is not only improving treatment efficiency but also ensuring better patient outcomes, making them an essential solution in the management of chronic conditions. This broader access to advanced healthcare options is fueling the demand for implantable ports, driving substantial growth in the global market.
As healthcare access continues to improve in emerging markets, there is substantial potential for growth in the implantable port market. These regions are witnessing significant advancements in medical infrastructure, including the availability of advanced medical technologies and trained healthcare professionals. Additionally, rising awareness of chronic diseases such as cancer, cardiovascular conditions, and autoimmune disorders is driving the demand for more effective and long-term treatment options. As patients in these markets increasingly require treatments like chemotherapy, dialysis, and intravenous nutrition, the adoption of implantable ports is expected to rise. Furthermore, as healthcare systems in emerging economies evolve and healthcare spending increases, the affordability and accessibility of implantable ports are likely to improve, allowing a broader population to benefit from this technology. This growing awareness, along with enhanced healthcare capabilities, presents a strong opportunity for implantable port manufacturers to expand their market presence in these regions. The growing aging population is creating significant opportunities for the expansion of the implantable global port market. As the elderly population increases, so does the prevalence of age-related chronic diseases such as cancer, cardiovascular diseases, diabetes, and renal failure, all of which often require long-term treatments that involve frequent intravenous access.
Implantable ports, which are surgically placed devices that provide a reliable and durable solution for administering treatments like chemotherapy, dialysis, and nutritional support, offer a less invasive and more comfortable alternative to traditional intravenous methods. With the aging demographic requiring more consistent and prolonged medical interventions, the demand for implantable ports has grown substantially. Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific will create lucrative growth opportunities in the o in years s er eri a’s ealth an in s a ro i ately illion ad lts a es and older ere livin in the US in 2022, and this number was projected to grow nearly 22% in the US in 2040. According to the European Commission, there were 448.8 million people, and more than one fifth of them were aged 65 years and over in Europe. As per the Asia-Pacific Report on Population Ageing 2022, there were approximately 670 million people aged 60 or older in Asia-Pacific in 2022. Also, it has been estimated that the number will double to approximately 1.3 billion people by 2050 in Asia-Pacific.
This demographic shift presents numerous opportunities for companies to innovate and expand their product offerings to meet the specific needs of elderly patients, who benefit from the reduced frequency of needle insertions and the increased comfort and safety that implantable ports provide. Furthermore, advancements in medical technology are making implantable ports more accessible, safer, and easier to use, further driving the adoption of these devices across healthcare systems. This combination of a growing aging population and improved healthcare solutions positions the implantable port market for continued growth and innovation.
High Cost of Implantation
The high cost of implantation is a significant restraint on the growth of the global implantable port market. The procedure involves not only the cost of the device itself, which can be expensive, but also the associated costs of surgical implantation, anesthesia, and post-operative care. These expenses make implantable ports less accessible, especially in low- and middle-income countries or for patients without sufficient insurance coverage. Additionally, the need for specialized healthcare professionals to perform the implantation adds to the overall cost. For many patients, the high upfront costs may deter them from opting for implantable ports, preferring less expensive alternatives like peripheral intravenous lines. This financial barrier limits the widespread adoption of implantable ports, especially in regions where healthcare budgets are constrained, and cost-effectiveness is a priority. As a result, the high cost of implantation continues to be a major factor restricting the market's growth potential.
Surgical Risks
The implantation of an implantable port is a surgical procedure that carries inherent risks, which can deter some patients from opting for this option. Potential complications include infection at the site of implantation, catheter-related issues, or damage to surrounding blood vessels. Additionally, there are risks associated with anesthesia, such as adverse reactions or complications during the procedure. While these risks are relatively rare, they are significant enough to make some patients hesitant, especially those with existing health conditions that might increase the likelihood of complications. These surgical risks can also lead to extended recovery times, added healthcare costs, or the need for follow-up procedures, further impacting patient willingness and healthcare provider decision-making. Consequently, the presence of surgical risks acts as a barrier to the broader adoption of implantable ports, particularly for patients seeking non-invasive treatment alternatives.
As healthcare access continues to improve in emerging markets, there is substantial potential for growth in the implantable port market. These regions are witnessing significant advancements in medical infrastructure, including the availability of advanced medical technologies and trained healthcare professionals. Additionally, rising awareness of chronic diseases such as cancer, cardiovascular conditions, and autoimmune disorders is driving the demand for more effective and long-term treatment options. As patients in these markets increasingly require treatments like chemotherapy, dialysis, and intravenous nutrition, the adoption of implantable ports is expected to rise. Furthermore, as healthcare systems in emerging economies evolve and healthcare spending increases, the affordability and accessibility of implantable ports are likely to improve, allowing a broader population to benefit from this technology. This growing awareness, along with enhanced healthcare capabilities, presents a strong opportunity for implantable port manufacturers to expand their market presence in these regions.
Growing Aging Population
The growing aging population is creating significant opportunities for the expansion of the implantable global port market. As the elderly population increases, so does the prevalence of age-related chronic diseases such as cancer, cardiovascular diseases, diabetes, and renal failure, all of which often require long-term treatments that involve frequent intravenous access. Implantable ports, which are surgically placed devices that provide a reliable and durable solution for administering treatments like chemotherapy, dialysis, and nutritional support, offer a less invasive and more comfortable alternative to traditional intravenous methods. With the aging demographic requiring more consistent and prolonged medical interventions, the demand for implantable ports has grown substantially.
Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific will create lucrative growth opportunities in the upcoming years. As per America’s Health Rankings, approximately 58 million adults ages 65 and older were living in the US in 2022, and this number was projected to grow nearly 22% in the US in 2040.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Implantable Port Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Company Headquarters: Écouen, France Founded: 1962 Workforce: ~ 2,327 Company Working: Vygon is a manufacturer of surgical and medical products. It provides products for anesthesia, oncology, urology, respiratory, neonatology, gynecology, and other medical disciplines. The company manufactures its products at facilities in the US, Europe, Mauritius, Colombia, and Colombia, and it sells them to independent practitioners and hospital staff members who are medical experts. The company's network of 27 companies and 308 distributors distributes more than 205 million goods annually in more than 120 countries. Furthermore, the company sells its products directly throughout the Americas, Europe, Asia, the Middle East, and Africa through a network of distributors.
7 interactive charts drawn from the Implantable Port Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Implantable Port Market By Region
Global Implantable Port Market By Insertion Method
Global Implantable Port Market By Country
Global Implantable Port Market By End User
Global Implantable Port Market By Application
Global Implantable Port Market By Material Type
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
